BioEquin FT suspensija injekcijām zirgiem
BioEquin FT suspensija injekcijām zirgiem
Authorised
- Clostridium tetani, toxoid
- Influenza A virus, subtype H3N8, strain A/equine/Brno/08, Inactivated
- Influenza A virus, subtype H3N8, strain A/equine/Morava/95, Inactivated
Product identification
Medicine name:
BioEquin FT suspensija injekcijām zirgiem
Active substance:
- Clostridium tetani, toxoid
- Influenza A virus, subtype H3N8, strain A/equine/Brno/08, Inactivated
- Influenza A virus, subtype H3N8, strain A/equine/Morava/95, Inactivated
Target species:
-
Horse
Route of administration:
-
Intramuscular use
Product details
Active substance and strength:
-
Clostridium tetani, toxoid30.00/international unit(s)1.00unit(s)
-
Influenza A virus, subtype H3N8, strain A/equine/Brno/08, InactivatedViena deva (1 ml) satur: ≥ 5 log2 HIT (specifisko antivielu vidējais ģeometriskais titrs jūrascūciņu asins serumā, noteikts ar hemaglutinācijas inhibīcijas testu)
-
Influenza A virus, subtype H3N8, strain A/equine/Morava/95, InactivatedViena deva (1 ml) satur: ≥ 5 log2 HIT (specifisko antivielu vidējais ģeometriskais titrs jūrascūciņu asins serumā, noteikts ar hemaglutinācijas inhibīcijas testu)
Pharmaceutical form:
-
Suspension for injection
Withdrawal period by route of administration:
-
Intramuscular use
-
Horse
-
Meat and offal0day
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI05AL01
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Latvia
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Bioveta a.s.
Marketing authorisation date:
Manufacturing sites for batch release:
- Bioveta a.s.
Responsible authority:
- Food And Veterinary Service
Authorisation number:
- V/NRP/20/0021
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
Latvian (PDF)
Published on: 11/12/2024
Package Leaflet
This document does not exist in this language (English). You can find it
in another language below.
Latvian (PDF)
Published on: 11/12/2024
Labelling
This document does not exist in this language (English). You can find it
in another language below.
Latvian (PDF)
Published on: 11/12/2024